Medicine and Dentistry
Acute Lymphoblastic Leukemia
100%
Chronic Myelogenous Leukemia
94%
Tyrosine-Kinase Inhibitor
82%
Pediatrics
75%
Patient
69%
Allogeneic Hematopoietic Stem Cell Transplantation
69%
Overall Survival
69%
Aplastic Anemia
60%
Child
56%
Spontaneous Remission
51%
Failure Free Survival
46%
Retrospective Study
45%
Droplet Digital Polymerase Chain Reaction
37%
Acute Myeloid Leukemia
37%
Central Nervous System
37%
Peripheral Blood Stem Cell Transplantation
37%
Hodgkin's Lymphoma
37%
Kidney Tumour
37%
Pediatric Hematology
37%
Next Generation Sequencing
32%
Event Free Survival
30%
Therapeutic Procedure
29%
Pediatrics Patient
25%
Blast Cell Crisis
25%
Dasatinib
24%
Hematopoietic Stem Cell Transplantation
23%
Cumulative Incidence
23%
Acute B-Cell Lymphoblastic Leukemia
23%
Haploidentical Hematopoietic Stem Cell Transplantation
22%
Quantitative Reverse Transcription Polymerase Chain Reaction
22%
Prognostic Factor
22%
Diagnosis
21%
Lymphoma
21%
Conditioning
21%
Whole Body Radiation
18%
Toddlers
18%
Young Adult
18%
Induction Chemotherapy
18%
Case Report
18%
Omicron Coronavirus Variant
18%
Minimal Residual Disease
18%
Myelodysplastic Syndrome
18%
Intensive Care
18%
COVID-19
18%
Observational Study
18%
Assay
18%
Immunoglobulin
18%
Adolescence
18%
Engraftment
18%
Steroid Treatment
18%
Biochemistry, Genetics and Molecular Biology
Failure Free Survival
61%
Overall Survival
56%
Next Generation Sequencing
45%
Conditioning
45%
Clonality
37%
Peripheral Blood Stem Cell Transplantation
37%
Allogeneic Hematopoietic Stem Cell Transplantation
37%
Host
37%
T Cell
31%
B Cell
27%
Event Free Survival
25%
Haploidentical Hematopoietic Stem Cell Transplantation
23%
PTPN11
18%
Bone Marrow Failure
18%
Pediatrics
18%
Insulin-Like Growth Factor 1
18%
Immunoglobulin
18%
Hematopoietic Stem Cell Transplantation
18%
Clonal Variation
18%
Immune Checkpoints
18%
Gene Mutation
18%
Intravenous Immunoglobulin
18%
Clonal Variation
18%
Bone Density
18%
Immunoglobulin Gene
18%
Cell Transplantation
18%
Survival Rate
18%
Low Drug Dose
18%
T Cell Depletion
18%
Hematopoietic Cell
18%
Exome Sequencing
15%
Myeloid
13%
Mutated Genes
12%
FBXW7
12%
Cytotoxic T Cell
11%
Flow Cytometry
8%
Stem Cell
7%
Whole Genome Sequencing
7%
KRAS
6%
Somatic Mutation
6%
Karyotype
6%
Gene Rearrangement
6%
Immunology and Microbiology
Myeloid
72%
Aplastic Anemia
61%
Failure Free Survival
47%
Overall Survival
45%
Allogeneic Hematopoietic Stem Cell Transplantation
44%
Peripheral Blood Stem Cell Transplantation
37%
Conditioning
31%
Next Generation Sequencing
28%
Event Free Survival
25%
Hematopoietic Stem Cell Transplantation
24%
Haploidentical Hematopoietic Stem Cell Transplantation
23%
Quantitative Reverse Transcription Polymerase Chain Reaction
22%
Immunoglobulin Gene
22%
Engraftment
18%
Intravenous Immunoglobulin
18%
Intravenous Immunoglobulin
18%
Viral Load
18%
Omicron Coronavirus Variant
18%
Clonal Variation
18%
COVID-19
18%
Whole Exome Sequencing
18%
Clonal Variation
18%
Dynamics
18%
Tyrosine
18%
T Cell
18%
Immunity
18%
B Cell
14%
Cytotoxic T Cell
13%
Reverse Transcription Polymerase Chain Reaction
11%
Graft-Versus-Host Disease
11%
Neutrophil
9%
Cycle Threshold
9%
Whole Genome Sequencing
9%
Chronic Graft Versus Host Disease
8%
Programmed Death 1 Ligand 1
8%
Acute Graft Versus Host Disease
7%
Stem Cell
7%
Polymerase Chain Reaction
7%
Gene Rearrangement
6%
Human Leukocyte Antigen
5%